Publication: Severe hepatotoxicity secondary to nintedanib.
No Thumbnail Available
Identifiers
Date
2022
Authors
Librero Jiménez, Marta
Heredia Carrasco, Clara
Fernández Cano, María Del Carmen
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Nintedanib is a multikinase inhibitor used for the treatment of pulmonary idiopathic fibrosis. We present the first report published to date of severe hepatotoxicity and jaundice secondary to nintedanib.
Description
MeSH Terms
Chemical and Drug Induced Liver Injury
Humans
Idiopathic Pulmonary Fibrosis
Indoles
Humans
Idiopathic Pulmonary Fibrosis
Indoles